A panel of PTEN null and PTEN WT prostate cancer cell lines were treated with increasing concentrations of docetaxel for 24 h and PI3K/AKT pathway activation analysed in the docetaxel-persister cells by immunoblotting (Fig. 2a, b). The gene discussed is AKT1; the disease is Familial prostate cancer.